再鼎医药授出购股权和受限制股份单位
Core Viewpoint - Zai Ding Pharmaceutical (09688) announced the grant of stock options and restricted stock units as part of its 2024 equity incentive plan, indicating a focus on employee retention and motivation through equity compensation [1] Group 1 - The company granted a total of 25,000 American Depositary Shares (ADS) stock options to one grantee [1] - Additionally, the company awarded a total of 32,200 restricted stock units (RSUs) to seven grantees [1] - The grants are set to take effect on October 1, 2025, Eastern Time [1]